Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis. [electronic resource]
Producer: 20111014Description: 478-9 p. digitalISSN:- 1651-2057
- Adult
- Benzamides
- Humans
- Imatinib Mesylate
- Joints -- drug effects
- Male
- Nephrogenic Fibrosing Dermopathy -- diagnosis
- Piperazines -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Range of Motion, Articular
- Recovery of Function
- Severity of Illness Index
- Skin -- drug effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.